ScholarIQanswers from OpenAlex & ORCID
James D. Neaton
ResearcherPublications, citations & collaboration network
James D. Neaton is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James D. Neaton have?
ScholarIQindexed works
James D. Neaton has 370 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James D. Neaton have?
ScholarIQcitation count
James D. Neaton has 56,106 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James D. Neaton?
ScholarIQh-index
James D. Neaton has an h-index of 94 in OpenAlex.
What is the i10-index of James D. Neaton?
ScholarIQi10-index
James D. Neaton has an i10-index of 243 in OpenAlex.
What is the ORCID of James D. Neaton?
ScholarIQorcid
The ORCID for James D. Neaton is on the source record.
What is the OpenAlex record for James D. Neaton?
ScholarIQopenalex
The OpenAlex for James D. Neaton is on the source record.
What are the most-cited papers on James D. Neaton?
ScholarIQmost cited works
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Bertram Pitt, Willem J. Remme, Faı̈ez Zannad, James D. Neaton, Felipe A. Martínez, Barbara Roniker, Richard M. Bittman, Steve Hurley, Jay H. Kleiman, Marjorie Gatlin
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
David J. Gordon, Jeffrey L. Probstfield, Robert J. Garrison, James D. Neaton, William P. Castelli, J. D. Knoke, David R. Jacobs, Shrikant I. Bangdiwala, Herman A. Tyroler
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
Bertram Pitt, Philip A. Poole‐Wilson, Robert Segal, Felipe A Martinez, Kenneth Dickstein, A. John Camm, Marvin A. Konstam, Günter A.J. Riegger, George Klinger, James D. Neaton, Divakar Sharma, Balasamy Thiyagarajan
The Prevention and Treatment of Missing Data in Clinical Trials
Roderick J. A. Little, Ralph B. D’Agostino, Michael L. Cohen, Kay Dickersin, Scott S. Emerson, John T. Farrar, Constantine Frangakis, Joseph W. Hogan, Geert Molenberghs, Susan A. Murphy, James D. Neaton, Andrea Rotnitzky, Daniel O. Scharfstein, Weichung Joe Shih, Jay P. Siegel, Hal S. Stern
Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial
Hiroyasu Iso, David R. Jacobs, Deborah Wentworth, James D. Neaton, Jerome D. Cohen